Amryt Pharma Holdings Ltd
LSE:AMYT
Amryt Pharma Holdings Ltd
LSE:AMYT
Price:
143 GBX
-11.73%
Market Closed
Updated:
May 19, 2024
Amryt Pharma Holdings Ltd
EPS (Diluted)
|
Amryt Pharma Holdings Ltd
EPS (Diluted) Peer Comparison
Comparables:
GSK
AZN
INDV
HIK
DPH
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Amryt Pharma Holdings Ltd
LSE:AMYT
|
EPS (Diluted)
$0
|
CAGR 3-Years
7%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
EPS (Diluted)
£1
|
CAGR 3-Years
-6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
0%
|
|
|
AstraZeneca PLC
LSE:AZN
|
EPS (Diluted)
$4
|
CAGR 3-Years
10%
|
CAGR 5-Years
16%
|
CAGR 10-Years
10%
|
|
|
Indivior PLC
LSE:INDV
|
EPS (Diluted)
$0
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
EPS (Diluted)
$0
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-2%
|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
EPS (Diluted)
£0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Amryt Pharma Holdings Ltd's EPS (Diluted)?
EPS (Diluted)
-0.7
USD
-0.7
USD
Based on the financial report for Dec 31, 2020, Amryt Pharma Holdings Ltd's EPS (Diluted) amounts to -0.7 USD.
What is Amryt Pharma Holdings Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-9%
-9%
Over the last year, the EPS (Diluted) growth was 20%. The average annual EPS (Diluted) growth rates for Amryt Pharma Holdings Ltd have been 7% over the past three years , -9% over the past five years .
You don't have any saved screeners yet
